This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, J. Articles by Herring, B. P. Search for Related Content PubMed PubMed Citation Articles by Zhou, J. Articles by Herring, B. P.

Smooth Muscle-Specific Genes Are Differentially Sensitive to Inhibition by Elk-1

Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202-5120

Received 14 June 2005/ Returned for modification 1 July 2005/ Accepted 8 September 2005

Understanding the mechanism of smooth muscle cell (SMC) differentiation will provide the foundation for elucidating SMC-related diseases, such as atherosclerosis, restenosis, and asthma. In the current study, overexpression of Elk-1 in SMCs down-regulated expression of several endogenous smooth muscle-restricted proteins, including telokin, SM22, and smooth muscle -actin. In contrast, down-regulation of endogenous Elk-1 in smooth muscle cells increased the expression of only telokin and SM22, suggesting that smooth muscle-specific promoters are differentially sensitive to the inhibitory effects of Elk-1. Consistent with this, overexpression of the DNA binding domain of Elk-1, which acts as a dominant-negative protein by displacing endogenous Elk-1, enhanced the expression of telokin and SM22 without affecting expression of smooth muscle -actin. Elk-1 suppressed the activity of smooth muscle-restricted promoters, including the telokin promoter that does not contain a consensus Elk-1 binding site, through its ability to block myocardin-induced activation of the promoters. Gel mobility shift and chromatin immunoprecipitation assays revealed that Elk-1 binds to a nonconsensus binding site in the telokin promoter and Elk-1 binding is dependent on serum response factor (SRF) binding to a nearby CArG box. Although overexpression of the SRF-binding B-box domain of Elk-1 is sufficient to repress the myocardin activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain. In addition, reporter gene assays demonstrate that an intact Elk-1 binding site in the telokin promoter is required for Elk-1 to maximally inhibit promoter activity. Together, these data suggest that the differential sensitivity of smooth muscle-specific genes to inhibition by Elk-1 may play a role in the complex changes in smooth muscle-specific protein expression that are observed under pathological conditions.

This article has been cited by other articles:

• Zhang, H.-M., Li, L., Papadopoulou, N., Hodgson, G., Evans, E., Galbraith, M., Dear, M., Vougier, S., Saxton, J., Shaw, P. E. (2008). Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1. Nucleic Acids Res 36: 2594-2607 [Abstract] [Full Text]  
• Freddie, C. T., Ji, Z., Marais, A., Sharrocks, A. D. (2007). Functional interactions between the Forkhead transcription factor FOXK1 and the MADS-box protein SRF. Nucleic Acids Res 0: gkm528v1-10 [Abstract] [Full Text]  
• McDonald, O. G., Owens, G. K. (2007). Programming Smooth Muscle Plasticity With Chromatin Dynamics. Circ. Res. 100: 1428-1441 [Abstract] [Full Text]  
• Parmacek, M. S. (2007). Myocardin-Related Transcription Factors: Critical Coactivators Regulating Cardiovascular Development and Adaptation. Circ. Res. 100: 633-644 [Abstract] [Full Text]  
• Kawai-Kowase, K., Owens, G. K. (2007). Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 292: C59-C69 [Abstract] [Full Text]  
• Oettgen, P. (2006). Regulation of Vascular Inflammation and Remodeling by ETS Factors.. Circ. Res. 99: 1159-1166 [Abstract] [Full Text]  
• Herring, B. P., El-Mounayri, O., Gallagher, P. J., Yin, F., Zhou, J. (2006). Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am. J. Physiol. Cell Physiol. 291: C817-C827 [Abstract] [Full Text]  
• Pipes, G.C. T., Creemers, E. E., Olson, E. N. (2006). The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis.. Genes Dev. 20: 1545-1556 [Abstract] [Full Text]